Homecare Self-Monitoring Device Market

Homecare Self-Monitoring Device Market, by Type (Blood Pressure Monitors, Blood Glucose Monitors, SPO2 Monitoring Kit, ECG Machines, Sleep Testing Device, Others (Thermometers, Weight Scale, Among Others)), by application (Metabolic Disorders, Circulatory Disorders, Respiratory Track Disorder, Others (Weight Management And Others)), by device type (Wearable, Hand Held, Others (Patches And Others)), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Homecare Self-monitoring devices are consumer-grade devices that help to monitor the health of individuals at home. These devices are usually low-cost and easily procurable, and they can be operated by patients or their caretakers with minimal training. Healthcare monitoring has been of interest to researchers for a long time and daily monitoring is very important in chronic diseases such as asthma, diabetes, and hypertension. Various self-monitoring devices are used in homecare such as automatic blood pressure monitors, blood glucose monitors, pulse oximeters, electrocardiographs, digital thermometers, and infrared thermometers. Appointments at Doctor’s surgeries can now be a long wait, so self-monitoring at home will help patients monitor their conditions and ask for help if needed. Remote patient monitoring (RPM) devices allow providers to monitor, report, and analyze their patient’s acute or chronic conditions from outside the hospital or clinic setting.

Market Dynamics

Market players are increasing product approval by regulatory bodies, which is expected to drive the growth of the global homecare self-monitoring device market, over the forecast period. For instance, on April 14, 2023, Abbott. a U.S.-based medical devices and healthcare company got U.S. Food and Drug Administration (FDA) approval for FREESTYLE LIBRE 3 SYSTEM. It is continuous glucose monitoring (iCGM) system having features like the world's smallest, thinnest, and most discreet glucose sensor. The most accurate 14-day CGM system to help reduce time spent in hypoglycemia and improve overall glucose control. Painless to apply and wear with a simple piece applicator. The Real-time glucose alarms in self-monitoring devices let you know the minute your glucose is too high or too low.

Key features of the study:

This report provides an in-depth analysis of the global homecare self-monitoring device market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global homecare self-monitoring device market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Abbott- diabetes, Roche Diabetes Care, HELYXON HealthCare Solutions Private Ltd, GE HealthCare, ResMed, Inc., MIR Medical International Research USA. Inc, F. Hoffmann-La Roche Ltd, BAYER HEALTHCARE, OMRON Healthcare India, Guardian Connect system, InBody Asia., Medtronic plc, KARABINIS MEDICAL SA, Pulsatom Healthcare, Cofoe Medical Technology Co., Ltd, Pylo Health.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global homecare self-monitoring device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global homecare self-monitoring device market

Detailed Segmentation:

Global Homecare Self-Monitoring Device Market, By Type:

Blood Pressure Monitors

Blood Glucose Monitors

SPO2 Monitoring Kit

ECG Machines

Sleep Testing Device

Others (Thermometers, Weight Scale, Among Others)

Global Homecare Self-Monitoring Device Market, By Application:

Metabolic Disorders

Circulatory Disorders

Respiratory Track Disorder

Others (Weight Management And Others)

Global Homecare Self-Monitoring Device Market, By device type:

Wearable

Hand Held

Others (Patches And Others)

Global Homecare Self-Monitoring Device Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country/Region:

South Africa

Central Africa

North Africa

Company Profiles

Abbott- diabetes.*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Roche Diabetes Care

HELYXON HealthCare Solutions Private Ltd

GE HealthCare

ResMed, Inc.

MIR Medical International Research USA. Inc

F. Hoffmann-La Roche Ltd

BAYER HEALTHCARE

OMRON Healthcare India

Guardian Connect system

InBody Asia.

Medtronic plc

KARABINIS MEDICAL SA

Pulsatom healthcare

Cofoe Medical Technology Co.Ltd

Pylo Health

“*” marked represents similar segmentation in other categories in the respective section.